Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsJames Chih‐Hsin Yang, Lecia V. Sequist, Kenneth J. O’Byrne et al.|The Lancet Oncology|2015Cited by 1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialCaicun Zhou, Jianjun Zou, Gongyan Chen et al.|The Lancet Respiratory Medicine|2020Cited by 504
The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomyShugeng Gao, Yousheng Mao, Zhongheng Zhang et al.|Journal of Thoracic Disease|2017Cited by 58
International expert consensus on the management of bleeding during VATS lung surgeryLunxu Liu, Alessandro Brunelli, Jiandong Mei et al.|Annals of Translational Medicine|2019Cited by 42